Table 1.
Variable | Controls (N = 431) n (%) |
Patients (N = 431) n (%) |
p Value |
---|---|---|---|
Age (yrs) | <0.001 | ||
≤65 | 339 (78.7%) | 166 (38.5%) | |
>65 | 92 (21.3%) | 265 (61.5%) | |
Mean ± S.D. | 59.4 ± 7.1 | 68.6 ± 11.8 | <0.001 |
Gender | |||
Female | 159 (36.9%) | 159 (36.9%) | 1.000 |
Male | 272 (63.1%) | 272 (63.1%) | |
Tobacco consumption | 0.071 | ||
No | 275 (63.8%) | 300 (69.6%) | |
Yes | 156 (36.2%) | 131 (30.4%) | |
Stage | |||
Non muscle invasive tumor (pTa–pT1) | 235 (54.5%) | ||
Muscle invasive tumor (pT2–pT4) | 196 (45.5%) | ||
Tumor T status | |||
Ta | 90 (20.9%) | ||
T1-T4 | 341 (79.1%) | ||
Lymph node status | |||
N0 | 380 (88.2%) | ||
N1+N2 | 51 (11.8%) | ||
Metastasis | |||
M0 | 417 (96.8%) | ||
M1 | 14 (3.2%) | ||
Histopathologic grading | |||
Low grade | 53 (12.3%) | ||
High grade | 378 (87.7%) |
Student’s t test or chi-squared test was used between controls and patients with UCC.